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Abstract
Objectives:  to  determine  the  prevalence  of  pulmonary  hemorrhage  in  newborns  and  evaluate
the associated  risk  factors  and  outcomes.
Methods:  this  was  a  retrospective  case-control  study  involving  67  newborns  who  met  the  criteria
for pulmonary  hemorrhage.  A  control  was  selected  for  each  case:  the  next-born  child  of  the  same
gender,  similar  weight  (±  200  g)  and  gestational  age  (±  1  week),  with  no  previous  pulmonary
hemorrhage  and  no  malformation  diagnosis.  Factors  previous  to  pulmonary  hemorrhage  onset,
as  well  as  aspects  associated  to  the  condition,  were  assessed.
Results:  the  prevalence  was  6.7  for  1,000  live  births,  and  the  rates  observed  were:  8%
among newborns  <  1,500  g,  and  11%  among  newborns  <  1,000  g.  Intubation  in  the  delivery  room
(OR  =  7.16),  SNAPPE  II  (OR  =  2.97),  surfactant  use  (OR  =  3.7),  and  blood  components  used  previ-
ously  to  pulmonary  hemorrhage  onset  (OR  =  5.91)  were  associated  with  pulmonary  hemorrhage.
In  the  multivariate  logistic  regression  model,  only  intubation  in  delivery  room  and  previous
use  of  blood  components  maintained  the  association.  Children  with  pulmonary  hemorrhage  had
higher  mortality  (OR  =  7.24).  Among  the  survivors,  the  length  of  stay  (p  ≤  0.01)  and  mechanical
ventilation  time  were  longer  (OR  =  25.6),  and  oxygen  use  at  36  weeks  of  corrected  age  was
higher  (OR  =  7.67).
Conclusions:  pulmonary  hemorrhage  is  more  prevalent  in  premature  newborns,  and  is  associ-
ated with  intubation  in  the  delivery  room  and  previous  use  of  blood  components,  leading  to
high  mortality  and  worse  clinical  evolution.
©  2014  Sociedade  Brasileira  de  Pediatria.  Published  by  Elsevier  Editora  Ltda.  
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Prevalência,  fatores  de  risco  e  prognóstico  associados  à  hemorragia  pulmonar
em  recém-nascidos
Resumo
Objetivos:  determinar  a  prevalência  de  hemorragia  pulmonar  entre  os  recém-nascidos  inter-
nados no  servic¸o e  avaliar  os  fatores  de  risco  e  prognóstico  associados.
Métodos:  estudo  retrospectivo  caso-controle  com  67  recém-nascidos  que  preencheram  os
critérios  pré-estabelecidos  de  hemorragia  pulmonar.  Para  cada  caso,  foi  selecionado  um  con-
trole:  a  próxima  crianc¸a nascida  do  mesmo  sexo,  com  semelhantes  peso  (±  200  g),  idade
gestacional  (±  1  semana)  e  sem  hemorragia  pulmonar  ou  malformac¸ões.  Foram  estudados
fatores  prévios  à  ocorrência  da  hemorragia  pulmonar  e  aspectos  decorrentes  do  evento.
Resultados:  a  prevalência  foi  de  6,7  a  cada  1.000  nascidos  vivos,  sendo  de  8%  entre  os  recém-
nascidos menores  que  1.500  g  e  de  11%  entre  os  recém-nascidos  menores  que  1.000  g.  A
necessidade  de  intubac¸ão  (IOT)  em  sala  de  parto  (OR  =  7,16),  uso  de  hemoderivados  previamente
à  ocorrência  de  hemorragia  pulmonar  (OR  =  5,91),  uso  de  surfactante  (OR  =  3,7)  e  SNAPPE  II  ≥30
(OR  =  2,97)  foram  associados  à  hemorragia  pulmonar.  No  modelo  de  regressão  logística  multi-
variado,  a  necessidade  de  IOT  (OR  =  5,12)  e  uso  de  hemoderivados  (OR  =  4,2)  mantiveram  essa
associac¸ão.  As  crianc¸as  com  hemorragia  pulmonar  apresentaram  maior  mortalidade  (OR  =  7,24),
e,  entre  as  sobreviventes,  maior  tempo  de  internac¸ão  (p  ≤  0,01),  mais  uso  de  oxigênio  com  36
semanas  (OR  =  7,67)  e  maior  durac¸ão  da  ventilac¸ão  mecânica  (OR  =  35,6).
Conclusão:  a  hemorragia  pulmonar  é  uma  doenc¸a de  maior  prevalência  em  recém-nascidos
pré-termos, e  está  associada  à  intubac¸ão  em  sala  de  parto  e  ao  uso  prévio  de  hemoderivados,
acarretando maior  mortalidade  e  pior  evoluc¸ão  clínica  das  crianc¸as.
© 2014  Sociedade  Brasileira  de  Pediatria.  Publicado  por  Elsevier  Editora  Ltda.  
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Until  the  1990s,  pulmonary  hemorrhage  (PH)  was  more
often diagnosed  in  threshold  preterm  newborns,  mainly  in
cases of  asphyxiation  or  those  with  serious  diseases.  Cur-
rently, it  is  more  often  described  in  extremely  preterm
newborns.1
Depending  on  the  criteria  used  to  deﬁne  PH,  preva-
lence rates  reported  in  very  low  birth  weight  newborns
range between  3%  and  32%.2--5 In  Brazil,  two  studies  were
retrieved: one  was  based  on  autopsies  of  newborns,  with
a prevalence  of  34.5%  of  PH,6 and  another  was  conducted
in newborns  weighing  <  1,500  g,  showing  a  prevalence  of
9%.7
No  Brazilian  study  has  assessed  the  perinatal  factors  asso-
ciated with  PH.  In  international  studies,  the  following  are
reported as  risk  factors  for  the  occurrence  of  PH:  intra-
partum asphyxia,  infection,  persistent  ductus  arteriosus,
need for  resuscitation  in  the  delivery  room,  low  gestational
age (GA)  and  birth  weight,  use  of  surfactant  therapy,  and
lack antenatal  corticosteroid  use.1,8 Regarding  prognosis,
there are  controversial  data  on  neuromotor  development;
some studies  have  shown  no  impact,2,5 whereas  others  have
demonstrated increased  risk  of  cerebral  palsy  and  cognitive
disorders.9 Regarding  mortality,  studies  show  a  rate  between
38% and  57%.2,10,11
Considering  the  scarcity  of  more  current  Brazilian  and
international information  about  PH,  this  study  aimed  to
determine the  prevalence  and  associated  risk  factors  and
prognosis of  newborns  with  PH.
a
aatients and methods
n  observational,  retrospective,  case-control  study  was  per-
ormed, assessing  all  children  born  at  the  Hospital  das
línicas de  Ribeirão  Preto  (HCRMRP-USP)  from  January  1,
005 to  January  31,  2010,  who  had  a  diagnosis  of  PH.  The
tudy was  approved  by  the  Ethics  Committee  of  HCFMRPU-SP
HCRP n.  3773/2010).
A total  of  109  patients  had  their  medical  records
eviewed, and  the  67  who  met  the  inclusion  criteria  were
elected for  study.
PH was  deﬁned  as  the  presence  of  hemorrhagic  ﬂuid
n the  trachea,  accompanied  by  signiﬁcant  clinical  dete-
ioration. For  newborns  not  on  ventilatory  support,  the
eed for  endotracheal  intubation  and  mechanical  venti-
ation was  deﬁned  as  an  important  clinical  deterioration,
hereas for  patients  who  were  already  on  mechanical
entilation, it  was  deﬁned  as  the  need  to  increase  inspi-
atory pressure  or  inspired  oxygen  fraction  by  at  least
0%.
The next  newborn  admitted  after  the  case  was  consid-
red as  control,  providing  it  was  of  the  same  gender,  of
imilar GA  (±  1  week),  and  had  a  difference  in  birth  weight
ompared to  the  case  that  did  not  exceed  200  g.
Antenatal  variables,  including  treatment  with
orticosteroids12 and  maternal  infection  (maternal  fever,nd/or bacterial  growth  in  maternal  cultures)  were
nalyzed.
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Regarding  the  children,  the  following  data  were
ecorded: gender,  GA  in  weeks  (New  Ballard  Score13 or  cal-
ulated by  ultrasonography),  weight,  birth  weight  adequacy
n relation  to  GA  according  to  Alexander’s  curve,14 Apgar
core in  the  ﬁrst  and  ﬁfth  minutes,  need  for  intubation  in
he delivery  room,15 SNAPPE  II,16 (Score  for  Neonatal  Acute
hysiology, Perinatal  Extension,  Version  II).  Assessed  in  the
rst 24  hours  of  life,  use  of  surfactant  therapy,  number  of
urfactant doses  (both  pre-PH),  time  elapsed  between  birth
nd hemorrhagic  episode  and  between  the  last  surfactant
ose and  the  hemorrhagic  episode  (for  cases  only),  pres-
nce of  patent  ductus  arteriosus  before  the  onset  of  PH,
se of  volume  expanders  and  total  volume  infused  up  to  six
ours  before  the  hemorrhagic  episode  (for  controls,  they
ere veriﬁed  six  hours  before  the  age  of  occurrence  in  the
orresponding case),  adequacy  of  the  total  volume  given  to
he newborn  calculated  according  to  birth  weight,  and  days
f life.17
As  prognostic  variables,  the  need  for  oxygen  at  28  days
nd at  36  weeks  of  corrected  age,  duration  of  mechanical
entilation and  use  of  nasal  CPAP,  presence  of  perintraven-
ricular hemorrhage  (PIVH)  according  to  the  classiﬁcation  of
apile,18 type  of  outcome  (discharge  or  death),  and  age  of
ccurrence were  assessed.
The  statistical  analysis  was  performed  with  the
AS/STAT® software  9.2  (NC,  USA).  Means,  medians,
nd standard  deviations  were  calculated  for  continuous
ariables, after  evaluation  of  normal  distribution:  the
roups were  compared  by  Student’s  t-test.  For  categorical
ariables, the  odds  ratios  (OR)  and  their  conﬁdence  inter-
als (CI)  were  calculated.  Data  were  adjusted  in  logistic
egression models,  quantifying  the  association  between
he dependent  variable  (PH)  and  the  independent  ones.
nalyzing the  67  pairs  (case/control)  and  considering  the
ean rate  of  intubation  for  infants  born  weighing  <  1,500  g
t  the  service  as  55.9%  (mean  data  of  the  last  three  years),
t would  be  possible  to  detect  differences  with  a  minimum
R of  2.86  for  a  test  with  80%  power.
esults
rom  January  1,  2005  to  January  31,  2010,  9,983  chil-
ren were  born  in  HCFMRPU-SP.  Of  these,  109  newborns
ere identiﬁed  with  PH,  of  whom  67  met  the  previously
roposed criteria  for  PH  and  were  considered  as  cases.
hus, the  prevalence  of  PH  in  newborns  in  HCFMRPU-SP  was
.7 per  1,000  births  and  among  those  whose  birth  weight
as ≤  1,500  g  was  8%,  and  11%  among  those  with  birth
eight ≤  1,000  g.
The prevalence  of  PH  among  hospitalized  newborns  was
.62%. The  mean  (±  SD)  age  at  which  PH  occurred  was
6 ±  93  hours,  and  the  mean  time  from  the  last  dose  of
urfactant was  54  ±  93  hours.
The  main  neonatal  and  postnatal  characteristics  of  the
hildren studied  are  described  in  Table  1.  The  analysis  of
ntenatal factors  (use  of  corticosteroids  before  delivery  and
aternal infection)  showed  no  difference  between  groups.
egarding the  birth  conditions,  newborns  who  had  PH  were
ore often  intubated  in  the  delivery  room  (88.1%  vs.  50.8%).
hen analyzing  the  use  of  surfactant,  newborns  who  had  PH
eceived surfactants  more  frequently  than  the  control  group
o
t
d
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76.1%  vs.  46.3%),  and  the  total  number  of  doses  was  greater
or the  group  with  PH.
Newborns  who  had  PH  showed  a higher  proportion  of
NAPPE II  ≥  30.  The  use  of  blood  products  (plasma  and
acked red  blood  cells)  six  hours  before  the  episode  was
ore frequent  in  the  group  with  PH  (53.7%  vs  16.4%).  Fig.  1
raphically shows  the  OR  values  of  all  studied  variables.
Table  2  shows  the  adjustment,  by  logistic  regression,  of
he variables  associated  with  PH  in  the  univariate  analy-
is, in  which  only  the  need  for  tracheal  intubation  and  use
f blood  products  maintained  the  association.  When  adjus-
ing the  model  using  variables  with  the  highest  association,
onsidering that  two  of  them,  SNAPPE  II  ≥  30  and  surfactant
se, had  not  shown  signiﬁcance  in  the  ﬁrst  analysis,  both
ariables maintained  the  association.
When  analyzing  the  clinical  outcome  in  the  two  groups
Table 3),  the  group  with  PH  needed  longer  time  of  mechan-
cal ventilation  than  controls,  and  also  showed  greater
requency of  oxygen  use  at  36  weeks  of  corrected  age.  There
as an  association  between  PH  and  evolution  with  perintra-
entricular bleeding,  especially  in  the  most  severe  cases.
atients who  had  PH  died  more  often  than  those  in  the  con-
rol group  (65%  vs.  21%),  and  those  who  survived  had  a  longer
ean hospital  stay  than  controls.
When  the  OR  for  these  variables  was  adjusted  for  antena-
al corticosteroid  use  and  SNAPPE  II,  duration  of  mechanical
entilation, use  of  oxygen  at  36  weeks  of  age,  and  the  death
utcome remained  signiﬁcant.
iscussion
everal  studies  aiming  to  deﬁne  factors  associated  with
he occurrence  of  PH  and  physiopathological  mechanisms
nvolved with  it  can  be  retrieved  in  the  literature.2--5,9--11,19,20
owever,  most  clinical  studies  are  old;  therefore,  there  is
 possibility  that  new  therapies  can  modify  the  proﬁle  of
ffected patients,  as  well  as  factors  most  often  associated
ith the  disease.  No  studies  performed  in  Brazil  or  in  devel-
ping countries  assessing  the  factors  associated  with  PH
ere retrieved.
In the  present  study,  92.4%  of  newborns  who  had  PH  were
orn weighing  less  than  1,500  g,  and  77.6%  had  less  than  29
eeks of  GA,  a  clear  indication  that  PH  is  associated  with
rematurity and  its  complications.
Among  prenatal  factors,  the  use  of  antenatal  cortico-
teroids has  been  identiﬁed  as  an  important  protective
actor against  the  occurrence  of  PH,19 especially  in  pregnant
omen with  GA  between  24  and  26  weeks.  This  effect  is
ttributed to  the  increased  production  of  surfactant  and
ossible structural  changes  in  fetal  pulmonary  vessels.  In  the
resent study,  only  37.3%  of  children  who  had  PH  and  49.7%
f children  in  the  control  group  received  antenatal  cortico-
teroids, lower  values  than  those  reported  by  the  Brazilian
etwork on  Neonatal  Research,12 which  reduced  the  ana-
yzed sample  size,  making  it  difﬁcult  to  demonstrate  the
ossible protective  effect  of  the  drug.
Maternal  chorioamnionitis  could  lead  to  an  acceleration
f lung  maturation  in  preterm  infants,  thus  exerting  a  pro-
ective effect  on  the  incidence  and  severity  of  respiratory
istress syndrome  of  the  newborn.21 However,  this  effect  is
ccompanied by  an  increased  susceptibility  of  the  newborn
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Table  1  Neonatal  and  postnatal  characteristics  of  the  children  studied.
Pulmonary  hemorrhage  (n  =  67)  Controls  (n  =  67)  OR  (95%  CI)
Maternal  use  of  corticosteroids  25  (37.3%)  33  (49.7%)  1.59  (0.8  to  3.1)
Maternal infection  16  (23.9%)  22  (32.8%)  1.53  (0.7  to  3.2)
Apgar 5th  min  <  7  19  (28.4%)  11  (16.5%)  2.01  (0.8  to  4.6)
Intubation in  delivery  room  59  (88.1%)  34  (50.8%)  7.16  (2.9  to  17.2)
Surfactant use 51 (76.1%)  31  (46.3%)  3.7  (1.7  to  7.7)
> than  one  dose  of  surfactant 23 (45.1%) 11  (35.5%) 4.7 (1.8  to  11.9)
SNAPPE II  ≥  30 47 (71.2%) 30  (45.4%) 2.9 (1.4  to  6.1)
Patent ductus  arteriosus  44  (65.7%)  39  (41.7%)  1.3  (0.6  to  2.7)
Previous use  of  indomethacin  6  (8.9%)  4  (5.9%)  1.5  (0.4  to  5.7)
Volume given  6  h  before  was
inadequate
44 (65.6%)  36  (53.7%)  1.4  (0.6  to  2.7)
Use of  volumetric  expansion  6  h
before
4  (5.9%)  2  (2.9%)  2.0  (0.3  to  11.6)
Use of  blood  products  6  h  before  36  (53.7%)  11(16.4%)  5.9  (2.6  to  13.2)
Weight, grams  (Mean  ±  SD)  864  ±  457  945  ±  455  p  =  0.30
Gestational  age,  weeks
(Mean ±  SD)
28  ±  2.8  28.5  ±  2.8  p  =  0.32
Female  gender  58.2%  58.2%  p  =  1
Small  for  gestational  age  55.2%  44.8%  p  =  0.18
a
7
t
tOR, odds ratio; CI, conﬁdence interval. SD, standard deviation.
lung  to  postnatal  insults,  possibly  through  the  action  of
released inﬂammatory  factors.21 The  balance  between
the two  effects  could  lead  to  PH.  In  the  present  study,  no
association was  found  between  maternal  infection  and  PH.
The  mean  time  for  the  occurrence  of  PH  was  76  hours
after birth  and  54  hours  after  the  last  surfactant  dose.
It is,  therefore,  a  relatively  early  event.  These  ﬁndings
had been  reported  in  previous  studies,  in  which  the  mean
e
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Figure  1  Odds  ratio  of  factors  associage  of  occurrence  of  PH  varied  between  40  h4,5,19 and
2 h.10
An  association  was  found  between  the  need  for  intuba-
ion in  the  delivery  room  and  the  presence  of  PH,  similar
o the  ﬁnding  of  Berger  et  al.19 This  association  remained
ven when  analyzed  in  a  multivariate  logistic  regression
odel. Other  studies  found  no  such  association.5,22 The  need
or intubation  and  ventilation  with  positive  pressure  and
Adjusted OR
10 15 20 25 30
ted  with  pulmonary  hemorrhage.
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Table  2  Multivariate  analysis.  Odds  ratio  (OR)  adjusted  for  factors  associated  with  hemorrhage.
Adjusted  OR  1  (95%  CI)  Adjusted  OR  2  (95%  CI)  Adjusted  OR  3  (95%  CI)
Tracheal  intubation  7.49  (1.94  to  28.89)  4.43  (1.46  to  13.48)  5.12  (2.04  to  12.8)
SNAPPE  II  ≥  30  1.10  (0.31  to  3.89)  0.95  (0.35  to  2.62)
Surfactant use 2.41  (0.9  to  6.47) 2.34  (0.98  to  5.57)
Patent ductus  arteriosus 0.93  (0.37  to  2.37)
Inadequate  volume 0.86  (0.35  to  2.18)
Blood  products  4.18  (1.58  to  11.04)  3.79  (1.58  to  9.04)  4.2  (1.78  to  9.80)
CI, conﬁdence interval.
Adjusted  OR 1: all signiﬁcant variables in the univariate analysis.
Adjusted  OR 2 and 3: variables with the highest association in the previous model.
Table  3  Variables  associated  with  the  prognosis  of  studied  children.  Crude  OR  of  prognostic  variables  and  adjusted  OR  for  use
of antenatal  corticosteroids  and  SNAPPE  II.
Crude  OR  (95%  CI)  Adjusted  OR  (95%  CI)
Time  of  mechanical  ventilation  ≥  10  days  25.7  (3.22  to  204.8)  33.1  (3.43  to  318.6)
Time  of  nasal  CPAP  ≥  10  days  2.44  (0.72  to  8.27)  3.35  (0.91  to  12.44)
Use  of  oxygen  at  28  days 2.35  (0.82  to  6.73)  1.87  (0.60  to  5.82)
Use  of  oxygen  at  36  weeks 7.67  (2.06  to  28.48) 8.23 (1.89  to  35.9)
PIVH  Grades  3  and  4 3.57  (1.51  to  8.43)  2.48  (0.98  to  6.33)
Death  7.24  (3.33  to  15.73) 6.20 (2.74  to  14.04)
Time  of  hospital  stay  (days)a (Mean  ±  SD) 110.8  ±  82.6  78  ±  66.4
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cPIVH, peri-intraventricular hemorrhage; SD, standard deviation.
a p ≤ 0.01.
xygen,  is  not  only  an  indicator  of  neonatal  hypoxia,  pul-
onary disease,  or  extreme  prematurity,  but  can  also  lead
o excessive  alveolar  distension,  causing  stress  damage  to
he alveolar  capillaries,  thereby  contributing  to  the  gene-
is of  PH.19 Despite  this  association,  when  the  Apgar  values
t the  ﬁrst  and  ﬁfth  minutes  were  analyzed,  no  association
ith PH  was  observed.  Other  case-control  studies  also  did
ot ﬁnd  this  association.5,10,22
SNAPPE  II,16 which  is  an  excellent  predictor  of  neona-
al survival,23 was  used  to  evaluate  the  association  between
linical severity  of  the  newborn  within  the  ﬁrst  hours  of  life
nd risk  of  PH.  An  association  was  found  between  SNAPPE  II
 30  and  PH  in  the  univariate  analysis,  but  the  association
as not  maintained  when  analyzed  in  a  multivariate  logis-
ic regression  model.  Only  the  study  by  Berger  et  al.19 had
ssessed this  association,  ﬁnding  an  increased  risk  of  PH  in
atients with  SNAPPE  II  ≥  24.
The  use  of  surfactant  also  showed  an  association,  includ-
ng greater  risk  as  the  number  of  doses  increased.  However,
his association  was  not  maintained  when  analyzed  in  a
ultivariate logistic  regression  model.  Although  the  meta-
nalysis performed  20  years  ago  by  Raju  and  Langenberg3
emonstrated  that  the  use  of  surfactant  increased  the
isk of  PH  by  approximately  50%,  other  studies  in  which
 similar  multivariate  analysis  was  performed  showed  no
ssociation.19,24
Kluckow  et  al.25 reported  that  newborns  with  PH  used
ore albumin  than  those  without  it  (83%  vs.  44%,  p  =  0.02).
his was  the  only  study  that  correlated  the  use  of  a  blood
roduct with  the  PH  episode.  In  the  present  study,  pre-
ious use  of  blood  products  (plasma  or  packed  red  blood
ells) showed  a  difference  between  groups,  maintaining  the
s
n
n
wssociation  even  when  adjusted  in  a  multivariate  logistic
egression model.  The  use  of  blood  products  prior  to  the
H episode  could  have  caused  a  sudden  increase  in  blood
olume, leading  to  a  stress  injury  of  the  capillary  wall,  with
assage of  ﬂuid  and  plasma  proteins,  which  can  also  lead
o left  ventricular  failure,  contributing  to  an  increase  in
ulmonary capillary  pressure,  as  already  proposed  by  Cole
t al.20
In  2011,  Polglase  et  al.26 demonstrated  that  immediately
fter an  intravenous  volume  overload,  lambs  had  an  increase
n pulmonary  blood  ﬂow  and  left  ventricular  ejection  vol-
me; 50%  of  them  had  PH.  The  elevation  in  pulmonary
apillary pressure  can  lead  to  alveolar  capillary  wall  injury,
ausing pulmonary  edema  due  to  increased  permeability
ith passage  of  proteins.27,28 In  the  present  study,  there  was
o difference  between  the  volumes  infused  24  h  before  the
nset of  hemorrhage  in  cases  and  controls.  No  difference
as observed,  either,  regarding  patients  who  received  vol-
me expansion  with  saline  solution  prior  to  the  episode;
owever, the  number  of  patients  was  very  small  in  both
roups (four  of  them  with  PH  and  two  controls).
Regarding  the  presence  of  patent  ductus  arteriosus
PDA), Klucow  and  Evans25 performed  echocardiograms
n newborns  before  the  PH  episode,  showing  that  they
ad signiﬁcant  PDA  and  increased  pulmonary  blood  ﬂow
hen compared  to  newborns  who  did  not  have  PH.  Some
tudies10,22 have  shown  this  association;  however,  other
ase-control studies  did  not  ﬁnd  it.2,4,5,11,19 In  the  present
tudy, this  association  was  not  found;  however,  it  should  be
oted that  this  was  a  retrospective  analysis  and  there  was
o systematic  evaluation  of  echocardiograms  in  all  cases,
hich reduced  the  impact  of  this  analysis.
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Regarding  the  prognostic  variables,  this  study  found  a
high mortality  rate  among  children  that  had  PH  (75.8%
vs. 30.3%),  with  a  seven-fold  higher  risk  of  death  when
compared to  controls.  Other  studies  have  reported  mortal-
ity rates  of  47-91%.2,4,10 A  Brazilian  study  showed  that  PH
was an  independent  risk  factor  of  death  in  newborns  with
GA <  32  weeks.29
Children  with  PH  who  survived  had  a  higher  mean  of
mechanical ventilation  than  controls.  This  difference  could
be explained  by  the  fact  that  children  who  had  PH  had  a
more severe  evolution,  requiring  more  aggressive  mechani-
cal ventilation,  whereas  the  controls  were  able  to  keep  good
levels of  oxygenation  and  ventilation,  with  less  aggressive
mechanical ventilation  (nCPAP).
The  use  of  oxygen  at  36  weeks  of  corrected  age  can  be
used as  an  indicator  of  lung  lesion  severity.  In  the  present
study, an  association  was  observed  between  PH  and  oxygen
use; this  association  remained  even  when  the  value  was  cor-
rected in  logistic  regression.  In  the  literature,  only  one  study
found this  association.22
The  combination  of  PH  with  perintraventricular  hemor-
rhage (PIVH)  was  analyzed  by  Pandit  et  al.,2 who  found  a
three-fold higher  risk  of  PIVH  grades  III  and  IV  in  children
who had  PH,  similar  to  the  initial  univariate  analysis  of  the
present study.  However,  when  the  results  were  corrected  for
use of  antenatal  maternal  corticosteroids  and  SNAPPE  II,  it
became non-signiﬁcant,  demonstrating  that  these  variables
could also  be  associated  with  the  etiology  of  PIVH.
The  occurrence  of  PH  signiﬁcantly  increases  the  risk  of
death in  newborns  and  its  effects  are  very  detrimental
even when  the  child  survives,  which  can  be  inferred  by
the increased  duration  of  oxygen  use  and  hospitalization  in
patients who  had  PH.
The  present  study  has  limitations,  as  it  is  a  case-control
retrospective study.  The  relative  rarity  of  PH  complicates
the design  of  a  prospective  study,  as  there  were  only  67
cases that  met  the  criteria  for  PH  in  a  ﬁve-year  period,
which limited  the  assessment  of  clinical  outcomes  due  to
the small  sample  size.  Nevertheless,  the  sample  size  led
to a  99.9%  power  to  detect  the  difference  found  in  the
two variables  that  were  associated  with  PH.  As  the  study
period increases,  there  is  risk  of  the  effect  from  changes
in therapeutic  approaches  that  occur  very  quickly.  Thus,
the results  should  be  interpreted  according  to  these  limi-
tations.
Another aspect  to  be  considered  as  a  limitation  of  this
retrospective study  was  the  incapacity  to  consistently  and
accurately obtain  data  on  mechanical  ventilation  between
possible variables  associated  with  PH,  as  ventilation  with
high tidal  volumes  is  associated  with  volutrauma,  which
may play  an  important  role  in  the  physiopathology  of  PH,
considering that  the  need  for  intubation  and  ventilation  in
the delivery  room  with  a  self-inﬂating  balloon  performed
at the  time,  without  PEEP  (Positive  end-expiratory  pressure)
and with  no  control  of  peak  inspiratory  pressure,  could  lead
to overdistention,  facilitating  pulmonary  injury.
The  results  of  this  study  indicate  that  PH  is  a  more  preva-
lent disease  in  newborn  preterm  infants  weighing  less  than
1,000 g  at  birth,  and  is  associated  with  intubation  in  the
delivery room  and  previous  use  of  blood  products,  result-
ing in  higher  mortality  and  worse  clinical  outcome  in  these
children.
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